Motley Fool Speculates About Fresenius Purchase of NxStage
Will NxStage stock price volatility affect he sale of NxStage to purchaser Fresenius Medical Care? Time will tell, and revenues are up, but profits are not.
Read the full article » | Posted 06-12-2018
- Baxter & Ayogo A Go Posted 08-11-2020
- Quanta to the Rescue! Posted 07-09-2020
- Baxter Reports PD Sharesource Data at ERA-EDTA Virtual Congress Posted 07-09-2020
- Fresenius Plans 100+ New Transitional Care Units in 2020 Posted 07-09-2020